A Microbiota-Dependent Response to Anticancer Treatment in an In Vitro Human Microbiota Model: A Pilot Study With Hydroxycarbamide and Daunorubicin

BACKGROUND: Anticancer drug efficacy is linked to the gut microbiota’s composition, and there is a dire need to better understand these interactions for personalized medicine. In vitro microbiota models are promising tools for studies requiring controlled and repeatable conditions. We evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hobson, Claire Amaris, Vigué, Lucile, Magnan, Mélanie, Chassaing, Benoit, Naimi, Sabrine, Gachet, Benoit, Claraz, Pauline, Storme, Thomas, Bonacorsi, Stephane, Tenaillon, Olivier, Birgy, André
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198576/
https://www.ncbi.nlm.nih.gov/pubmed/35719352
http://dx.doi.org/10.3389/fcimb.2022.886447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198576/
https://www.ncbi.nlm.nih.gov/pubmed/35719352
http://dx.doi.org/10.3389/fcimb.2022.886447

Ejemplares similares